Correlation Between Vivos Therapeutics and Cerus

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vivos Therapeutics and Cerus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vivos Therapeutics and Cerus into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vivos Therapeutics and Cerus, you can compare the effects of market volatilities on Vivos Therapeutics and Cerus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vivos Therapeutics with a short position of Cerus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vivos Therapeutics and Cerus.

Diversification Opportunities for Vivos Therapeutics and Cerus

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Vivos and Cerus is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Vivos Therapeutics and Cerus in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerus and Vivos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vivos Therapeutics are associated (or correlated) with Cerus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerus has no effect on the direction of Vivos Therapeutics i.e., Vivos Therapeutics and Cerus go up and down completely randomly.

Pair Corralation between Vivos Therapeutics and Cerus

Given the investment horizon of 90 days Vivos Therapeutics is expected to under-perform the Cerus. In addition to that, Vivos Therapeutics is 1.45 times more volatile than Cerus. It trades about -0.01 of its total potential returns per unit of risk. Cerus is currently generating about -0.01 per unit of volatility. If you would invest  225.00  in Cerus on September 20, 2024 and sell it today you would lose (67.00) from holding Cerus or give up 29.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Vivos Therapeutics  vs.  Cerus

 Performance 
       Timeline  
Vivos Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vivos Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Vivos Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Cerus 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cerus has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Vivos Therapeutics and Cerus Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vivos Therapeutics and Cerus

The main advantage of trading using opposite Vivos Therapeutics and Cerus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vivos Therapeutics position performs unexpectedly, Cerus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerus will offset losses from the drop in Cerus' long position.
The idea behind Vivos Therapeutics and Cerus pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Correlations
Find global opportunities by holding instruments from different markets